Company Mission
Vaxiva’s vision is to become a leading Japan/Asia regional development and commercialization engine for advanced human vaccine products which satisfy unmet consumer and public health needs. Vaxiva is accomplishing this via strategic licensing and development-through-partnership to develop novel vaccines and vaccine delivery systems. Vaxiva’s basic strategy can be summarized as follows:
- I. Development of unique vaccines products through partnerships with vaccine antigen manufacturers and developers, combining their antigens with Vaxiva’s proprietary vaccine adjuvant platforms
- - and -
-
- II. Acquisition and commercialization of novel, proprietary
vaccine antigens and technologies, with an emphasis on those that
synergize with Vaxiva’s existing projects